Key facts
- This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Apr 2025, 16:04.
Michael Egholm - 04 Apr 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- LAB
- Reported as of
- 04 Apr 2025
- Net transaction value
- -$61,713
- SEC form
- 4
- Accepted by SEC
- 08 Apr 2025, 16:04:11 UTC
- Prior SEC filing
- 24 Mar 2025
- Next SEC filing
- 22 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Egholm by Hanjoon Alex Kim, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 08 Apr 2025.
Change
- Previous filing in this sequence was filed on 24 Mar 2025.
- Current net transaction value: -$61,713.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LAB
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +196,512
- Change %
- +7.5%
- Price
- $0.000000
- Shares after
- 2,832,518
- Date
- 04 Apr 2025
- Ownership
- Direct
LAB
transaction
Common Stock
Tax liability
- Transaction value
- $61,713
- Shares
- -57,676
- Change %
- -2%
- Price
- $1.07
- Shares after
- 2,774,842
- Date
- 04 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LAB
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -196,512
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 196,513
- Date
- 04 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 196,512
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022.
Footnote F2
Each RSU represents the contingent right to receive one share of the Issuer's common stock.
Footnote F3
On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023.